It was indicated that overexpression of ER-α66 decreased the sensitivity of Bcap37 cells (ER-α66 negative) to paclitaxel, suggesting a possible role of ER in chemosensitivity of breast cancer [76]. Here, ESR1 is linked to breast cancer.